|
1
|
Anderson JR, Armitage JO and Weisenburger
DD: Epidemiology of the non-Hodgkin's lymphomas: Distributions of
the major subtypes differ by geographic locations. Non-Hodgkin's
Lymphoma Classification Project. Ann Oncol. 9:717–720. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takata K, Okada H, Ohmiya N, Nakamura S,
Kitadai Y, Tari A, Akamatsu T, Kawai H, Tanaka S, Araki H, et al:
Primary gastrointestinal follicular lymphoma involving the duodenal
second portion is a distinct entity: A multicenter, retrospective
analysis in Japan. Cancer Sci. 102:1532–1536. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sentani K, Maeshima AM, Nomoto J, Maruyama
D, Kim SW, Watanabe T, Kobayashi Y, Tobinai K and Matsuno Y:
Follicular lymphoma of the duodenum: A clinicopathologic analysis
of 26 cases. Jpn J Clin Oncol. 38:547–552. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Campo E, Swerdlow SH, Harris NL, Pileri S,
Stein H and Jaffe ES: The 2008 WHO classification of lymphoid
neoplasms and beyond: Evolving concepts and practical applications.
Blood. 117:5019–5032. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmatz A-I, Streubel B, Kretschmer-Chott
E, Püspök A, Jäger U, Mannhalter C, Tiemann M, Ott G, Fischbach W,
Herzog P, et al: Primary follicular lymphoma of the duodenum is a
distinct mucosal/submucosal variant of follicular lymphoma: A
retrospective study of 63 cases. J Clin Oncol. 29:1445–1451. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jakić-Razumović J and Aurer I: The World
Health Organization classification of lymphomas. Croat Med J.
43:527–534. 2002.PubMed/NCBI
|
|
7
|
Rohatiner A, d'Amore F, Coiffier B,
Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem
P, Shipp M, et al: Report on a workshop convened to discuss the
pathological and staging classifications of gastrointestinal tract
lymphoma. Ann Oncol. 5:397–400. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Federico M, Bellei M, Marcheselli L,
Luminari S, Lopez-Guillermo A, Vitolo U, Pro B, Pileri S, Pulsoni
A, Soubeyran P, et al: Follicular lymphoma international prognostic
index 2: A new prognostic index for follicular lymphoma developed
by the international follicular lymphoma prognostic factor project.
J Clin Oncol. 27:4555–4562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Armitage JO and Weisenburger DD: New
approach to classifying non-Hodgkin's lymphomas: Clinical features
of the major histologic subtypes. Non-Hodgkin's Lymphoma
Classification Project. J Clin Oncol. 16:2780–2795. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Misdraji J, del Castillo Fernandez C and
Ferry JA: Follicle center lymphoma of the ampulla of Vater
presenting with jaundice: Report of a case. Am J Surg Pathol.
21:484–488. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamamoto S, Nakase H, Yamashita K,
Matsuura M, Takada M, Kawanami C and Chiba T: Gastrointestinal
follicular lymphoma: Review of the literature. J Gastroenterol.
45:370–388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bende RJ, Smit LA, Bossenbroek JG, Aarts
WM, Spaargaren M, de Leval L, Boeckxstaens GE, Pals ST and van
Noesel CJ: Primary follicular lymphoma of the small intestine:
alpha4beta7 expression and immunoglobulin configuration suggest an
origin from local antigen-experienced B cells. Am J Pathol.
162:105–113. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chouhan J, Batra S, Gupta R and Guha S:
Gastrointestinal follicular lymphoma: Using primary site as a
predictor of survival. Cancer Med. 5:2669–2677. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Damaj G, Verkarre V, Delmer A,
Solal-Celigny P, Yakoub-Agha I, Cellier C, Maurschhauser F,
Bouabdallah R, Leblond V, Lefrère F, et al: Primary follicular
lymphoma of the gastrointestinal tract: A study of 25 cases and a
literature review. Ann Oncol. 14:623–629. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kodama M, Kitadai Y, Shishido T, Shimamoto
M, Fukumoto A, Masuda H, Tanaka S, Yoshihara M, Sakai A, Nakayama H
and Chayama K: Primary follicular lymphoma of the gastrointestinal
tract: A retrospective case series. Endoscopy. 40:343–346. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shia J, Teruya-Feldstein J, Pan D, Hegde
A, Klimstra DS, Chaganti RS, Qin J, Portlock CS and Filippa DA:
Primary follicular lymphoma of the gastrointestinal tract: A
clinical and pathologic study of 26 cases. Am J Surg Pathol.
26:216–224. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marcus R, Imrie K, Belch A, Cunningham D,
Flores E, Catalano J, Solal-Celigny P, Offner F, Walewski J, Raposo
J, et al: CVP chemotherapy plus rituximab compared with CVP as
first-line treatment for advanced follicular lymphoma. Blood.
105:1417–1423. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hiddemann W, Kneba M, Dreyling M, Schmitz
N, Lengfelder E, Schmits R, Reiser M, Metzner B, Harder H,
Hegewisch-Becker S, et al: Frontline therapy with rituximab added
to the combination of cyclophosphamide, doxorubicin, vincristine
and prednisone (CHOP) significantly improves the outcome for
patients with advanced-stage follicular lymphoma compared with
therapy with CHOP alone: Results of a prospective randomized study
of the German Low-Grade Lymphoma Study Group. Blood. 106:3725–3732.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Herold M, Haas A, Srock S, Neser S, Al-Ali
KH, Neubauer A, Dölken G, Naumann R, Knauf W, Freund M, et al:
Rituximab added to first-line mitoxantrone, chlorambucil, and
prednisolone chemotherapy followed by interferon maintenance
prolongs survival in patients with advanced follicular lymphoma: An
east german study group hematology and oncology study. J Clin
Oncol. 25:1986–1992. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Colombat P, Brousse N, Salles G,
Morschhauser F, Brice P, Soubeyran P, Delwail V, Deconinck E,
Haioun C, Foussard C, et al: Rituximab induction immunotherapy for
first-line low-tumor-burden follicular lymphoma: Survival analyses
with 7-year follow-up. Ann Oncol. 23:2380–2385. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Friedberg JW, Byrtek M, Link BK, Flowers
C, Taylor M, Hainsworth J, Cerhan JR, Zelenetz AD, Hirata J and
Miller TP: Effectiveness of first-line management strategies for
stage I follicular lymphoma: Analysis of the National LymphoCare
Study. J Clin Oncol. 30:3368–3375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Davis TA, Grillo-López AJ, White CA,
McLaughlin P, Czuczman MS, Link BK, Maloney DG, Weaver RL,
Rosenberg J and Levy R: Rituximab anti-CD20 monoclonal antibody
therapy in non-Hodgkin's lymphoma: Safety and efficacy of
re-treatment. J Clin Oncol. 18:3135–3143. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kahl BS, Hong F, Williams ME, Gascoyne RD,
Wagner LI, Krauss JC, Habermann TM, Swinnen LJ, Schuster SJ,
Peterson CG, et al: Rituximab extended schedule or re-treatment
trial for low-tumor burden follicular lymphoma: Eastern cooperative
oncology group protocol e4402. J Clin Oncol. 32:3096–3102. 2014.
View Article : Google Scholar : PubMed/NCBI
|
